Bromofluoromethane Speciality Gases for Late-Stage Fluoromethylation BFM’s well known commercial use is in a late-stage fluoromethylation of a thioacid to yield fluticasone propionate (API found in Flonase® and Advair®) (Figure 1) or fluticasone furoate (Breo®) by GlaxoSmithKline. O O O HO H H F F O SH F Br H H K2CO3, DMF -60°C to 0°C 78% O O O O HO S F H H F F In general, BFM has also proven in the flouromethylation of enolates, phenols and oximes and is useful to provide access to a variety of compounds. Two exemplary approaches for BFM as fluoromethylation reagent are shown in Figure 2. The properties of BFM are well studied [Eur. J. Inorg. Chem. 2015, 5357-5362]. F R1 Br H H B OR OR F R1 N R2 OH N R2 O F R2 = cyclic rest - 9 2 7 3 7 1 7 3 7, 3 , 4 9 9 1 . m e h C . d e M . J : 1 . g F i . t n e g a e r s a M F B r o f . g e . : 2 . g F i Name: Purity: CAS: Formula: Bromofluoromethane Boiling point: 99,5% / 99,9% (pharma grade) Melting point: +17.5°C -121°C [373-52-4] CH2BrF Density at 20°C: 1.76 gcm-3 Density at 50°C : 1.66 gcm-3 Molecular weight: 112.93 gmol-1 Vapor pressure at 50°C: 2.25 bar Colour: colourless Stability at 20°C: 18 months Gute Chemie 3 2 - . 1 3 2 6 0 . 6 0 7 9 8 5 BrHFH